Accelerate Diagnostics, Inc (AXDX) Financial Statements (2025 and earlier)

Company Profile

Business Address 3950 S. COUNTRY CLUB ROAD #470
TUCSON, AZ 85714
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 3826 - Laboratory Analytical Instruments (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

12/31/2024
Q4
9/30/2024
Q3
6/30/2024
Q2
3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:20,9009,70015,80013,20021,20030,700
Cash and cash equivalent19,6918,58814,60612,13820,16229,282
Short-term investments1,2211,1581,1451,0819891,000
Other undisclosed cash, cash equivalents, and short-term investments(12)(46)49(19)49418
Receivables2,0272,2892,2172,6222,6662,342
Inventory, net of allowances, customer advances and progress billings2,9783,2233,2493,3103,5535,106
Inventory2,9783,2233,2493,3103,5535,106
Prepaid expense5297981,0683801,4351,274
Other current assets9901,1141,8481,5163,6382,812
Other undisclosed current assets1246(49)3,438(49)5
Total current assets:27,43617,17024,13324,46632,44342,239
Noncurrent Assets
Finance lease, right-of-use asset, after accumulated amortization6269281,2251,5181,8072,091
Operating lease, right-of-use asset6127879571,1771,3521,527
Property, plant and equipment2,8783,1003,1972,3892,6092,896
Other noncurrent assets7638821,2101,8161,1131,125
Total noncurrent assets:4,8795,6976,5896,9006,8817,639
TOTAL ASSETS:32,31522,86730,72231,36639,32449,878
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities7,6546,4638,4598,0398,2497,262
Accounts payable4,7143,7595,1084,7964,8124,033
Accrued liabilities2,9402,7043,3513,2433,4373,229
Deferred revenue6717911,2721,545596478
Debt1152511,4111,3091,1941,906
Derivative instruments and hedges, liabilities     25,59842,786
Other undisclosed current liabilities9,8185,9084,9891,1412,1491,284
Total current liabilities:18,25813,41316,13112,03437,78653,716
Noncurrent Liabilities
Long-term debt and lease obligation58,05241,11937,73636,36433,59732,664
Long-term debt, excluding current maturities58,00541,06237,65536,10233,32732,289
Finance lease, liability475781262270375
Liabilities, other than long-term debt4,4863,2222,6352,8562,9742,161
Deferred revenue2,4691,1341,1101,1221,090 
Other liabilities2,0172,0051,1971,1641,0681,097
Operating lease, liability 833285708161,064
Total noncurrent liabilities:62,53844,34140,37139,22036,57134,825
Total liabilities:80,79657,75456,50251,25474,35788,541
Equity
Equity, attributable to parent, including:(48,481)(34,887)(25,780)(19,888)(35,033)(38,663)
Common stock2524211414 
Treasury stock, value(45,067)(45,067)(45,067)(45,067)(45,067)(45,067)
Additional paid in capital706,931705,280702,971694,634666,239663,812
Accumulated other comprehensive loss(1,057)(449)(618)(612)(360)(653)
Accumulated deficit(709,313)(694,675)(683,087)(668,857)(655,859)(656,769)
Other undisclosed equity, attributable to parent      14
Total equity:(48,481)(34,887)(25,780)(19,888)(35,033)(38,663)
TOTAL LIABILITIES AND EQUITY:32,31522,86730,72231,36639,32449,878

Income Statement (P&L) ($ in thousands)

12/31/2024
Q4
9/30/2024
Q3
6/30/2024
Q2
3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
Revenues2,9752,9862,9213,0273,2992,921
Cost of revenue
(Cost of Product and Service Sold)
(2,119)(2,310)(2,198)(2,394)(3,192)(2,122)
Gross profit:856676723633107799
Operating expenses(9,474)(9,282)(10,879)(11,363)(14,757)(13,384)
Operating loss:(8,618)(8,606)(10,156)(10,730)(14,650)(12,585)
Nonoperating income (expense)(6,021)(2,982)(4,074)(1,704)15,691(19,994)
Gain (loss), foreign currency transaction, before tax523(263)19241(428)25
Other nonoperating income (expense)6413(627)52(29)40
Income (loss) from continuing operations before income taxes:(14,639)(11,588)(14,230)(12,434)1,041(32,579)
Income tax expense    (564)(131)(156)
Other undisclosed income from continuing operations      
Net income (loss) available to common stockholders, diluted:(14,639)(11,588)(14,230)(12,998)910(32,735)

Comprehensive Income ($ in thousands)

12/31/2024
Q4
9/30/2024
Q3
6/30/2024
Q2
3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
Net income (loss):(14,639)(11,588)(14,230)(12,998)910(32,735)
Comprehensive income (loss):(14,639)(11,588)(14,230)(12,998)910(32,735)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(609)169(6)(252)293(22)
Comprehensive income (loss), net of tax, attributable to parent:(15,248)(11,419)(14,236)(13,250)1,203(32,757)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: